LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 133

Search options

  1. Article: Authors' response.

    Sharm, Jatin / Gautam, C S / Singh, Harmanjit / Singh, Jagjit

    The Indian journal of medical research

    2023  Volume 158, Issue 2, Page(s) 207–210

    Language English
    Publishing date 2023-08-09
    Publishing country India
    Document type Journal Article
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/0971-5916.384245
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Ferrite Nanoparticles as Catalysts in Organic Reactions

    Nilima Maji / Harmanjit Singh Dosanjh

    Magnetochemistry, Vol 9, Iss 156, p

    A Mini Review

    2023  Volume 156

    Abstract: Ferrites have excellent magnetic, electric, and optical properties that make them an indispensable choice of material for a plethora of applications, such as in various biomedical fields, magneto–optical displays, rechargeable lithium batteries, ... ...

    Abstract Ferrites have excellent magnetic, electric, and optical properties that make them an indispensable choice of material for a plethora of applications, such as in various biomedical fields, magneto–optical displays, rechargeable lithium batteries, microwave devices, internet technology, transformer cores, humidity sensors, high-frequency media, magnetic recordings, solar energy devices, and magnetic fluids. Recently, magnetically recoverable nanocatalysts are one of the most prominent fields of research as they can act both as homogeneous and heterogenous catalysts. Nano-ferrites provide a large surface area for organic groups to anchor, increase the product and decrease reaction time, providing a cost-effective method of transformation. Various organic reactions were reported, such as the photocatalytic decomposition of a different dye, alkylation, dehydrogenation, oxidation, C–C coupling, etc., with nano-ferrites as a catalyst. Metal-doped ferrites with Co, Ni, Mn, Cu, and Zn, along with the metal ferrites doped with Mn, Cr, Cd, Ag, Au, Pt, Pd, or lanthanides and surface modified with silica and titania, are used as catalysts in various organic reactions. Metal ferrites (MFe 2 O 4 ) act as a Lewis acid and increase the electrophilicity of specific groups of the reactants by accepting electrons in order to form covalent bonds. Ferrite nanocatalysts are easily recoverable by applying an external magnetic field for their reuse without significantly losing their catalytic activities. The use of different metal ferrites in different organic transformations reduces the catalyst overloading and, at the same time, reduces the use of harmful solvents and the production of poisonous byproducts, hence, serving as a green method of chemical synthesis. This review provides insight into the application of different ferrites as magnetically recoverable nanocatalysts in different organic reactions and transformations.
    Keywords ferrite ; nanocatalysts ; magnetic separation ; recyclable catalyst ; green synthesis ; Chemistry ; QD1-999
    Subject code 540
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study.

    Singh, Harmanjit / Rohilla, Ravi / Jaswal, Shivani / Singla, Mandeep

    Expert review of endocrinology & metabolism

    2024  Volume 19, Issue 1, Page(s) 81–87

    Abstract: Introduction: The objective of this study was to compare the effects of teneligliptin-based regimens and other gliptin-based regimens with respect to insulin resistance and glycemic control in patients with type 2 diabetes mellitus (T2DM).: Methods: ... ...

    Abstract Introduction: The objective of this study was to compare the effects of teneligliptin-based regimens and other gliptin-based regimens with respect to insulin resistance and glycemic control in patients with type 2 diabetes mellitus (T2DM).
    Methods: We enrolled T2DM subjects, inadequately controlled with metformin and glimepiride and taking one of the gliptins, and divided them into two groups, i.e. group 1 (teneligliptin-based regimens) and group 2 (other gliptin-based regimens). Fasting plasma insulin, adiponectin levels, homeostatic model assessment for insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), and fasting blood glucose (FBG) were measured and compared. Costs of different gliptins were noted, and mean cost of per day therapy was compared.
    Results: Eighty-six subjects participated in this study (43 each in group 1 and group 2). No significant differences were observed in FBG, HbA1c, insulin levels, and HOMA-IR, but the trend was in favor of teneligliptin-based regimens. A significantly higher number of subjects achieved HbA1c target in group 1 (
    Conclusion: Teneligliptin seems to be cost-effective and safer option in T2DM subjects who were not adequately controlled with metformin and sulfonylureas. However, further prospective studies are needed.
    MeSH term(s) Humans ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Diabetes Mellitus, Type 2 ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Cross-Sectional Studies ; Glycated Hemoglobin ; Insulin Resistance ; Glycemic Control ; Blood Glucose ; Metformin/therapeutic use ; Insulins
    Chemical Substances Dipeptidyl-Peptidase IV Inhibitors ; Hypoglycemic Agents ; 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine ; Glycated Hemoglobin ; Blood Glucose ; Metformin (9100L32L2N) ; Insulins
    Language English
    Publishing date 2024-01-01
    Publishing country England
    Document type Journal Article
    ISSN 1744-8417
    ISSN (online) 1744-8417
    DOI 10.1080/17446651.2023.2290486
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists.

    Singh, Harmanjit / Nim, Dwividendra Kumar / Randhawa, Aaronbir Singh / Ahluwalia, Saher

    Expert review of clinical pharmacology

    2024  Volume 17, Issue 4, Page(s) 381–391

    Abstract: Introduction: The integration of artificial intelligence (AI) into clinical pharmacology could be a potential approach for accelerating drug discovery and development, improving patient care, and streamlining medical research processes.: Areas covered! ...

    Abstract Introduction: The integration of artificial intelligence (AI) into clinical pharmacology could be a potential approach for accelerating drug discovery and development, improving patient care, and streamlining medical research processes.
    Areas covered: We reviewed the current state of AI applications in clinical pharmacology, focusing on drug discovery and development, precision medicine, pharmacovigilance, and other ventures. Key AI applications in clinical pharmacology are examined, including machine learning, natural language processing, deep learning, and reinforcement learning etc. Additionally, the evolving role of clinical pharmacologists, ethical considerations, and challenges in implementing AI in clinical pharmacology are discussed.
    Expert opinion: The AI could be instrumental in accelerating drug discovery, predicting drug safety and efficacy, and optimizing clinical trial designs. It can play a vital role in precision medicine by helping in personalized drug dosing, treatment selection, and predicting drug response based on genetic, clinical, and environmental factors. The role of AI in pharmacovigilance, such as signal detection and adverse event prediction, is also promising. The collaboration between clinical pharmacologists and AI experts also poses certain ethical and practical challenges. Clinical pharmacologists can be instrumental in shaping the future of AI-driven clinical pharmacology and contribute to the improvement of healthcare systems.
    MeSH term(s) Humans ; Artificial Intelligence ; Pharmacology, Clinical ; Machine Learning ; Physicians ; Biomedical Research
    Language English
    Publishing date 2024-02-15
    Publishing country England
    Document type Journal Article ; Review
    ISSN 1751-2441
    ISSN (online) 1751-2441
    DOI 10.1080/17512433.2024.2317963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses.

    Singh, Harmanjit / Sikarwar, Pallavi / Khurana, Supreet / Sharma, Jatin

    TouchREVIEWS in endocrinology

    2022  Volume 18, Issue 2, Page(s) 96–101

    Abstract: Statin use has been linked with new-onset diabetes mellitus (NODM). In the present systematic review, we aimed to determine the incidence of NODM with statin use by assessing and summarizing the data generated by different systematic reviews and ... ...

    Abstract Statin use has been linked with new-onset diabetes mellitus (NODM). In the present systematic review, we aimed to determine the incidence of NODM with statin use by assessing and summarizing the data generated by different systematic reviews and metaanalyses published on this topic. We conducted a systematic review of systematic reviews and meta-analyses using a pre-defined study protocol. Two authors independently performed a literature search using PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) for studies reporting data on statin use and NODM incidence and screened and extracted data for the outcomes of interest. The Assessing the Methodological Auality of Systematic Reviews 2 (AMSTAR 2) checklist was used to evaluate the quality of the included systematic reviews and meta-analyses. The initial search yielded 621 potential records, and 16 relevant systematic reviews and meta-analyses were included in the present systematic review. The included studies showed an increase in the risk of NODM with statin use. In particular, rosuvastatin and atorvastatin were associated with NODM in many systematic reviews or meta-analyses; however, pravastatin and pitavastatin were found to be associated with lower or no risk. We observed a positive trend of development of NODM with statin use became more evident with advancing years as more number of studies were added. Intensive doses of statins and use in older subjects were found to be important risk factors for NODM. Finally, the quality assessment revealed that the included systematic reviews and metaanalyses were of critically low or low quality. We concluded that statin use carries a risk of causing NODM. Statins should not be discouraged in anticipation of NODM. However, glycaemic monitoring should be encouraged with the on-going statin therapy. Furthermore, clinical studies addressing the use of statins and the incidence of NODM as their primary objective should be planned.
    Language English
    Publishing date 2022-11-29
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2752-5457
    ISSN (online) 2752-5457
    DOI 10.17925/EE.2022.18.2.96
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reconditioning of plant metabolism by arbuscular mycorrhizal networks in cadmium contaminated soils: Recent perspectives.

    Kaur, Harmanjit / Tashima / Singh, Sandeep / Kumar, Pankaj

    Microbiological research

    2022  Volume 268, Page(s) 127293

    Abstract: Cadmium (Cd) is one of the most perilous nonessential heavy metal for plants, owing to its high water solubility and obstruction with various physiological and biochemical processes. It enters food chain via plant uptake from contaminated soil, posing a ... ...

    Abstract Cadmium (Cd) is one of the most perilous nonessential heavy metal for plants, owing to its high water solubility and obstruction with various physiological and biochemical processes. It enters food chain via plant uptake from contaminated soil, posing a grave menace to ecosystem and mankind. Green remediation comprises approaches intended at prudent use of natural resources for increasing profits to humans and environment. Arbuscular mycorrhizal (AM) fungi are considered a promising green technological tool for remedial of Cd-polluted soils. They are naturally associated with root system of plants in Cd-contaminated soils, evidencing their tolerance to Cd. AM can decrease Cd uptake by plants broadly through two strategies: (1) extracellular mechanisms involving Cd chelation by root exudates, binding to fungal cell wall/structures or to the glycoprotein glomalin; (2) intracellular means involving transfer via hyphal network, detoxification and vacuolar sequestration mediated by complexation of Cd with glutathione (GSH), phytochelatins (PCs), metallothioneins (MTs) and polyphosphate granules. Additionally, mycorrhizal symbiosis facilitates reconditioning of plants' metabolism primarily through dilution effect, increased water and mineral uptake. Recently, AM-induced remodelling of root cell wall synthesis has been reported to improve plant vigor and survival under Cd stressed environments. The present article highlights Cd impacts on AM growth, its diversity in Cd contaminated soils, and variations among diverse AM fungal species for imparting plant Cd tolerance. The most recent perspectives on AM-mediated Cd tolerance mechanisms in plants, including cellular and molecular studies have also been reviewed for successful utilization of these beneficial microbes in sustainable agriculture.
    MeSH term(s) Humans ; Mycorrhizae/metabolism ; Cadmium/metabolism ; Plant Roots/microbiology ; Ecosystem ; Plants/metabolism ; Glutathione/metabolism ; Soil/chemistry ; Soil Pollutants/metabolism
    Chemical Substances Cadmium (00BH33GNGH) ; Glutathione (GAN16C9B8O) ; Soil ; Soil Pollutants
    Language English
    Publishing date 2022-12-22
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1189614-0
    ISSN 1618-0623 ; 0944-5013
    ISSN (online) 1618-0623
    ISSN 0944-5013
    DOI 10.1016/j.micres.2022.127293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Tafenoquine for

    Sharma, Jatin / Gautam, C S / Singh, Harmanjit / Singh, Jagjit

    The Indian journal of medical research

    2022  Volume 154, Issue 6, Page(s) 797–805

    Abstract: Plasmodium vivax (P. vivax) malaria is a major problem in various countries such as America, Southeast Asia, Africa and the Eastern Mediterranean. The major barrier in controlling P. vivax malaria is its ability to remain in the liver as a hypnozoite ... ...

    Abstract Plasmodium vivax (P. vivax) malaria is a major problem in various countries such as America, Southeast Asia, Africa and the Eastern Mediterranean. The major barrier in controlling P. vivax malaria is its ability to remain in the liver as a hypnozoite form which is responsible for relapse of P. vivax malaria; hence it is necessary to target both the blood (schizont) as well as the liver (hypnozoite) stages of P. vivax to prevent its relapse. A number of factors limit the use of primaquine (PQ), the currently available therapy for P. vivax (hypnozoite stage), such as haemolysis in glucose-6-phosphate dehydrogenase-deficient patients and being contraindicated in pregnant women. Another problem associated with PQ is the poor adherence rate to the 14-day treatment regimen. Single-dose tafenoquine (TQ), an 8-aminoquinoline, has recently been approved by the U.S. FDA for the treatment of P. vivax malaria along with a blood schizonticidal. TQ is active against all stages of P. vivax lifecycle. In published studies, TQ is considered a better alternative to PQ in terms of adherence, but there are some concerns regarding its safety, efficacy and study designs of trials conducted on TQ. In this context, this review, discusses the potential safety concerns, efficacy data, summary and an appraisal of findings of the important published trials of TQ.
    MeSH term(s) Aminoquinolines ; Antimalarials/adverse effects ; Female ; Humans ; Malaria, Vivax/drug therapy ; Plasmodium vivax ; Pregnancy ; Primaquine/adverse effects ; Recurrence
    Chemical Substances Aminoquinolines ; Antimalarials ; tafenoquine (262P8GS9L9) ; Primaquine (MVR3634GX1)
    Language English
    Publishing date 2022-05-07
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/ijmr.IJMR_1167_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study.

    Singh, Harmanjit / Arora, Ekta / Narula, Seerat / Singla, Mandeep / Otaal, Armaan / Sharma, Jatin

    Expert review of endocrinology & metabolism

    2023  Volume 18, Issue 4, Page(s) 347–354

    Abstract: Objective: To identify a preferred and cost-effective drug among Dipeptidyl peptidase-4 inhibitors (DPP4Is) for Indian patients with T2DM.: Methods: We performed a systematic literature search using standard databases for relevant literature. ... ...

    Abstract Objective: To identify a preferred and cost-effective drug among Dipeptidyl peptidase-4 inhibitors (DPP4Is) for Indian patients with T2DM.
    Methods: We performed a systematic literature search using standard databases for relevant literature. Original studies comparing the efficacy and/or safety of different DPP4Is were included. Two authors independently performed the literature search, screening, and collected relevant data from the selected studies. The costs of all brands of individual DPP4Is were noted and compared for lowest, highest, and average cost. Finally, we summarized the information with respect to Efficacy, safety, suitability, and cost to find the most cost-effective DPP4I.
    Results: We found 13 eligible studies containing data on 15,720 subjects. These studies showed similar efficacy (or better) and safety with teneligliptin as compared to other DPP4Is. Teneligliptin also showed additional benefits other than the glycemic control. The average cost per tablet of teneligliptin 20 mg was markedly lower as compared to sitagliptin, vildagliptin, and other commonly used DPP4Is. Teneligliptin also outscored other commonly used DPP4Is in India in suitability and seems to have better patient compliance.
    Conclusions: Teneligliptin 20 mg could be considered as the preferred and most cost-effective agent among commonly used DPP4Is for the effective management of patients with T2DM in India.
    MeSH term(s) Humans ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Hypoglycemic Agents ; Diabetes Mellitus, Type 2/drug therapy ; Cost-Benefit Analysis ; Blood Glucose ; Glycated Hemoglobin ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
    Chemical Substances Dipeptidyl-Peptidase IV Inhibitors ; 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine ; Hypoglycemic Agents ; Blood Glucose ; Glycated Hemoglobin ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases (EC 3.4.14.-)
    Language English
    Publishing date 2023-05-26
    Publishing country England
    Document type Systematic Review ; Journal Article
    ISSN 1744-8417
    ISSN (online) 1744-8417
    DOI 10.1080/17446651.2023.2216279
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Herbal Medicine- A Friend or a Foe of Cardiovascular Disease.

    Kaur, Harmanjit / Singh, Samneet / Kanagala, Sai Gautham / Gupta, Vasu / Patel, Meet A / Jain, Rohit

    Cardiovascular & hematological agents in medicinal chemistry

    2023  

    Abstract: Background: Herbal remedies are used by 80% of the Asian population in primary health care as per WHO. According to current research, the herbal medicine market was valued at nearly USD 166 billion in 2021 and is expected to reach approximately USD 348 ... ...

    Abstract Background: Herbal remedies are used by 80% of the Asian population in primary health care as per WHO. According to current research, the herbal medicine market was valued at nearly USD 166 billion in 2021 and is expected to reach approximately USD 348 billion by 2028. Increased incidence of chronic conditions such as diabetes, asthma, coronary artery disease, osteoarthritis, has fueled the growing interest in traditional herbal and plant-derived treatments among researchers. In addition, rural communities in developing nations have renewed interest in herbal treatments due to lower cost and easy availability.
    Objective: Aim of the paper is to highlight the role of five of more commonly used herbal medicines that are Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza in cardiovascular disorders.
    Methods: A PubMed search was done using the keywords Herbal Medicine, Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza. Articles which were available for free access were utilized. No formula inclusion or exclusion criteria was followed. A total of 42 papers were included for the study.
    Conclusion: Although there have been encouraging outcomes with the use of these herbal medications, many of these products are poorly monitored and are yet to be studied in detail regarding their adverse effects. Moreover, these medicinal products are known to interact with various drugs. To compete with the expanding pharmaceutical industry, more medicinally helpful herbal items must be used and scientifically validated.
    Language English
    Publishing date 2023-10-02
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2215710-4
    ISSN 1875-6182 ; 1871-5257
    ISSN (online) 1875-6182
    ISSN 1871-5257
    DOI 10.2174/0118715257251638230921045029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Amelioration of bleomycin induced pulmonary fibrosis by administration of Salvianolic acid B in mice.

    Begum, Gulzar / Singh, Nittin Dev / Leishangthem, Geeta Devi / Banga, Harmanjit Singh

    Veterinaria italiana

    2022  Volume 58, Issue 1, Page(s) 87–101

    Abstract: Pulmonary fibrosis is the end‑stage manifestation of wide range of respiratory diseases and during pulmonary fibrosis, pulmonary inflammation and epithelial‑mesenchymal transition (EMT) play important roles. Salvianolic acid B (SAB) from the herb Salviae ...

    Abstract Pulmonary fibrosis is the end‑stage manifestation of wide range of respiratory diseases and during pulmonary fibrosis, pulmonary inflammation and epithelial‑mesenchymal transition (EMT) play important roles. Salvianolic acid B (SAB) from the herb Salviae miltiorrhiza has been reported to possess an excellent anti‑inflammatory, antifibrotic and antioxidant activity. The present study aimed to investigate the ameliorative effect of SAB on bleomycin induced pulmonary fibrosis in mice. Adult albino mice were divided as SHAM/control group (saline alone), BLM group (bleomycin @ 1mg/kg intratracheally once) and SAB groups (BLM challenged once and SAB administration in three dosages @ 5, 10 and 15 mg/kg intraperitoneally daily for 30 days). Lungs wet/dry ratio and protein concentration in bronchoalveolar lavage fluid, MPO activity, oxidative stress markers, hydroxyproline assay, levels of inflammatory cytokines (TNF‑α, IL‑6 and TGF‑β1), NF‑κB activity, histopathology, immunostaining (E‑cadherin, vimentin and alpha ‑smooth muscle actin) and ultrastructural changes were studied. SAB showed anti‑inflammatory and anti‑fibrotic effects through inhibition of inflammatory cell infiltration, alveolar structure disruption, and collagen deposition and the expression of several fibrogenic cytokines. SAB also up‑regulate E‑cadherin and down‑regulated vimentin and alpha‑smooth muscle actin expression. In conclusion, Salvianolic acid B is effective in alleviating the BLM induced lung fibrosis through suppression of oxidative stress, inflammation, histological, ultrastructural changes and EMT.
    MeSH term(s) Mice ; Animals ; Bleomycin/toxicity ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/drug therapy ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/veterinary ; Vimentin/therapeutic use ; Actins ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Cytokines/metabolism ; Cytokines/therapeutic use ; Cadherins/therapeutic use
    Chemical Substances Bleomycin (11056-06-7) ; salvianolic acid B (C1GQ844199) ; Vimentin ; Actins ; Anti-Inflammatory Agents ; Cytokines ; Cadherins
    Language English
    Publishing date 2022-11-18
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2536397-9
    ISSN 1828-1427 ; 0505-401X
    ISSN (online) 1828-1427
    ISSN 0505-401X
    DOI 10.12834/VetIt.1703.9039.2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top